These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 25886260)
1. A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture. Raut R; Beesetti H; Tyagi P; Khanna I; Jain SK; Jeankumar VU; Yogeeswari P; Sriram D; Swaminathan S Virol J; 2015 Feb; 12():16. PubMed ID: 25886260 [TBL] [Abstract][Full Text] [Related]
2. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells. Beesetti H; Tyagi P; Medapi B; Krishna VS; Sriram D; Khanna N; Swaminathan S Antivir Ther; 2018; 23(5):385-394. PubMed ID: 29583121 [TBL] [Abstract][Full Text] [Related]
3. Discovery of antiviral molecules for dengue: In silico search and biological evaluation. Cabarcas-Montalvo M; Maldonado-Rojas W; Montes-Grajales D; Bertel-Sevilla A; Wagner-Döbler I; Sztajer H; Reck M; Flechas-Alarcon M; Ocazionez R; Olivero-Verbel J Eur J Med Chem; 2016 Mar; 110():87-97. PubMed ID: 26807547 [TBL] [Abstract][Full Text] [Related]
4. Antiviral activities of 15 dengue NS2B-NS3 protease inhibitors using a human cell-based viral quantification assay. Chu JJ; Lee RC; Ang MJ; Wang WL; Lim HA; Wee JL; Joy J; Hill J; Brian Chia CS Antiviral Res; 2015 Jun; 118():68-74. PubMed ID: 25823617 [TBL] [Abstract][Full Text] [Related]
5. Structure-guided Discovery of a Novel Non-peptide Inhibitor of Dengue Virus NS2B-NS3 Protease. Li L; Basavannacharya C; Chan KW; Shang L; Vasudevan SG; Yin Z Chem Biol Drug Des; 2015 Sep; 86(3):255-64. PubMed ID: 25533891 [TBL] [Abstract][Full Text] [Related]
6. Small molecule pan-dengue and West Nile virus NS3 protease inhibitors. Cregar-Hernandez L; Jiao GS; Johnson AT; Lehrer AT; Wong TA; Margosiak SA Antivir Chem Chemother; 2011 May; 21(5):209-17. PubMed ID: 21566267 [TBL] [Abstract][Full Text] [Related]
7. Screening of antiviral activities in medicinal plants extracts against dengue virus using dengue NS2B-NS3 protease assay. Rothan HA; Zulqarnain M; Ammar YA; Tan EC; Rahman NA; Yusof R Trop Biomed; 2014 Jun; 31(2):286-96. PubMed ID: 25134897 [TBL] [Abstract][Full Text] [Related]
8. Development of antiviral inhibitor against dengue 2 targeting Ns3 protein: In vitro and in silico significant studies. Padmapriya P; Gracy Fathima S; Ramanathan G; V Y; A KS; Kaveri K; Gunasekaran P; Tirichurapalli Sivagnanam U; Thennarasu S Acta Trop; 2018 Dec; 188():1-8. PubMed ID: 30145258 [TBL] [Abstract][Full Text] [Related]
9. Identification of covalent active site inhibitors of dengue virus protease. Koh-Stenta X; Joy J; Wang SF; Kwek PZ; Wee JL; Wan KF; Gayen S; Chen AS; Kang C; Lee MA; Poulsen A; Vasudevan SG; Hill J; Nacro K Drug Des Devel Ther; 2015; 9():6389-99. PubMed ID: 26677315 [TBL] [Abstract][Full Text] [Related]
10. High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease. Balasubramanian A; Manzano M; Teramoto T; Pilankatta R; Padmanabhan R Antiviral Res; 2016 Oct; 134():6-16. PubMed ID: 27539384 [TBL] [Abstract][Full Text] [Related]
11. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells. Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156 [TBL] [Abstract][Full Text] [Related]
12. Construction of dengue virus protease expression plasmid and in vitro protease assay for screening antiviral inhibitors. Lai H; Teramoto T; Padmanabhan R Methods Mol Biol; 2014; 1138():345-60. PubMed ID: 24696347 [TBL] [Abstract][Full Text] [Related]
13. Thiazolidinone-peptide hybrids as dengue virus protease inhibitors with antiviral activity in cell culture. Nitsche C; Schreier VN; Behnam MA; Kumar A; Bartenschlager R; Klein CD J Med Chem; 2013 Nov; 56(21):8389-403. PubMed ID: 24083834 [TBL] [Abstract][Full Text] [Related]
15. Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies. de Sousa LR; Wu H; Nebo L; Fernandes JB; da Silva MF; Kiefer W; Kanitz M; Bodem J; Diederich WE; Schirmeister T; Vieira PC Bioorg Med Chem; 2015 Feb; 23(3):466-70. PubMed ID: 25564380 [TBL] [Abstract][Full Text] [Related]
16. Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity. Takagi Y; Matsui K; Nobori H; Maeda H; Sato A; Kurosu T; Orba Y; Sawa H; Hattori K; Higashino K; Numata Y; Yoshida Y Bioorg Med Chem Lett; 2017 Aug; 27(15):3586-3590. PubMed ID: 28539222 [TBL] [Abstract][Full Text] [Related]
17. Antiviral cationic peptides as a strategy for innovation in global health therapeutics for dengue virus: high yield production of the biologically active recombinant plectasin peptide. Rothan HA; Mohamed Z; Suhaeb AM; Rahman NA; Yusof R OMICS; 2013 Nov; 17(11):560-7. PubMed ID: 24044366 [TBL] [Abstract][Full Text] [Related]
18. Phenylalanine and Phenylglycine Analogues as Arginine Mimetics in Dengue Protease Inhibitors. Weigel LF; Nitsche C; Graf D; Bartenschlager R; Klein CD J Med Chem; 2015 Oct; 58(19):7719-33. PubMed ID: 26367391 [TBL] [Abstract][Full Text] [Related]
19. Study the antiviral activity of some derivatives of tetracycline and non-steroid anti inflammatory drugs towards dengue virus. Rothan HA; Buckle MJ; Ammar YA; Mohammadjavad P; Shatrah O; Noorsaadah AR; Rohana Y Trop Biomed; 2013 Dec; 30(4):681-90. PubMed ID: 24522138 [TBL] [Abstract][Full Text] [Related]
20. Discovery of novel small molecule inhibitors of dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping. Deng J; Li N; Liu H; Zuo Z; Liew OW; Xu W; Chen G; Tong X; Tang W; Zhu J; Zuo J; Jiang H; Yang CG; Li J; Zhu W J Med Chem; 2012 Jul; 55(14):6278-93. PubMed ID: 22742496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]